Stocks and Investing Stocks and Investing
Wed, May 25, 2022
Tue, May 24, 2022

Salveen Richter Maintained (TSHA) at Strong Buy with Decreased Target to $16 on, May 24th, 2022


Published on 2024-10-27 21:16:41 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $27 to $16 on, May 24th, 2022.

Salveen has made no other calls on TSHA in the last 4 months.



There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 0 agree with Salveen's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Salveen


  • Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, May 17th, 2022
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $35 on, Friday, April 1st, 2022
  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $36 on, Friday, April 1st, 2022
  • Jack Allen of "Baird" Initiated at Buy and Held Target at $26 on, Wednesday, March 9th, 2022
  • Yanan Zhu of "Wells Fargo" Initiated at Buy and Held Target at $25 on, Tuesday, March 1st, 2022
Contributing Sources